Viewing StudyNCT00442312



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00442312
Status: UNKNOWN
Last Update Posted: 2007-03-01
First Post: 2007-02-27

Brief Title: Combigan Ophthalmic SolutionBrimonidine 02 and Timolol 05With Latanoprost Compared With Latanoprost Monotherapy
Sponsor: Genovate Biotechnology Co Ltd
Organization: Genovate Biotechnology Co Ltd

Organization Data

Organization: Genovate Biotechnology Co Ltd
Class: INDUSTRY
Study ID: COM 003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Genovate Biotechnology Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Allergan Medical INDUSTRY